Clinical trials recruiting for Safety

Phase breakdown

Drugs and treatments being studied

Self-screener

Recruiting trials

• Efficacy and Safety of AK104 Combined With Chemotherapy and Cetuximab or Bevacizumab
  NCT07253896 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Human Amniotic-Derived Mesenchymal Stem Cell Therapy for Calciphylaxis
  NCT04592640 · Phase: Early Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Observational of Adjuvant Treatment of Breast Cancer With Liposomal Doxorubicin Regimen
  NCT05731258 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• Radiotherapy Plus Anlotinib in LA-NSCLC Intolerable to cCRT
  NCT07037680 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy
  NCT07461220 · Phase: Phase 1, Phase 2 · Ages: 50 Years to 90 Years · Sex: All (male and female) · 14 locations
• Safety of Elacestrant in ER+/HER2- and ESR1 Mutations MBC
  NCT06544577 · Phase: Not specified · Ages: 18 Years and older · Sex: Female · 1 location

Related conditions

Trials recruiting for Safety often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Safety trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.